We are live on ! Find out more
ECA

Elevated Capital Advisors Portfolio holdings

AUM $364M Turnover 5.52%
1-Year Est. Return 17.23%
This Fund
S&P 500
This Quarter Est. Return
+9.98%
1 Year Est. Return
+17.23%
3 Year Est. Return
+45.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$364M
AUM Growth
-$33.7M
Cap. Flow
-$62.9M
Cap. Flow %
-17.29%
Top 10 Hldgs %
28.04%
Holding
870
New
27
Increased
84
Reduced
292
Closed
21
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.21%
2 Technology 9.82%
3 Financials 4.58%
4 Consumer Discretionary 2.9%
5 Healthcare 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HDB icon
751
HDFC Bank
HDB
$121B
$930 ﹤0.01%
36
– –
2025 Q4
2 quarters
IGV icon
752
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
$906 ﹤0.01%
10
– –
2025 Q4
2 quarters
BFH icon
753
Bread Financial
BFH
$3.83B
$867 ﹤0.01%
8
– –
2025 Q4
2 quarters
CDX icon
754
Simplify High Yield ETF
CDX
$319M
$866 ﹤0.01%
41
+1
+3% +$21
2025 Q4
2 quarters
LOGI icon
755
Logitech
LOGI
$14.9B
$846 ﹤0.01%
9
– –
2025 Q4
2 quarters
E icon
756
ENI
E
$82.6B
$843 ﹤0.01%
18
– –
2025 Q4
2 quarters
UL icon
757
Unilever
UL
$142B
$842 ﹤0.01%
14
– –
2025 Q4
2 quarters
BX icon
758
Blackstone
BX
$85B
$824 ﹤0.01%
7
– –
2025 Q4
2 quarters
EW icon
759
Edwards Lifesciences
EW
$49.5B
$814 ﹤0.01%
9
– –
2025 Q4
2 quarters
BSX icon
760
Boston Scientific
BSX
$63.8B
$811 ﹤0.01%
19
– –
2025 Q4
2 quarters
SNY icon
761
Sanofi
SNY
$97.1B
$811 ﹤0.01%
19
– –
2025 Q4
2 quarters
GEN icon
762
Gen Digital
GEN
$14.6B
$796 ﹤0.01%
32
– –
2025 Q4
2 quarters
HIG icon
763
Hartford Financial Services
HIG
$36.2B
$795 ﹤0.01%
6
– –
2025 Q4
2 quarters
PTC icon
764
PTC
PTC
$21B
$795 ﹤0.01%
7
– –
2025 Q4
2 quarters
EFX icon
765
Equifax
EFX
$18.7B
$794 ﹤0.01%
5
– –
2025 Q4
2 quarters
BABA icon
766
Alibaba
BABA
$273B
$782 ﹤0.01%
8
– –
2025 Q4
2 quarters
BCS icon
767
Barclays
BCS
$76.7B
$779 ﹤0.01%
29
– –
2025 Q4
2 quarters
FAST icon
768
Fastenal
FAST
$57.3B
$768 ﹤0.01%
16
– –
2025 Q4
2 quarters
PDD icon
769
Pinduoduo
PDD
$116B
$763 ﹤0.01%
10
– –
2025 Q4
2 quarters
FHB icon
770
First Hawaiian
FHB
$3.03B
$762 ﹤0.01%
26
– –
2025 Q4
2 quarters
IBB icon
771
iShares Biotechnology ETF
IBB
$10.6B
$761 ﹤0.01%
4
– –
2025 Q4
2 quarters
FBT icon
772
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.92B
$744 ﹤0.01%
3
– –
2025 Q4
2 quarters
HUBS icon
773
HubSpot
HUBS
$12B
$730 ﹤0.01%
4
– –
2025 Q4
2 quarters
HLN icon
774
Haleon
HLN
$44.1B
$728 ﹤0.01%
78
– –
2025 Q4
2 quarters
TOPT icon
775
iShares Top 20 U.S. Stocks ETF
TOPT
$769M
$724 ﹤0.01%
22
– –
2026 Q1
1 quarter

Similar funds

Elevated Capital Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Elevated Capital Advisors held 870 positions worth $364M, down 8.5% from $397M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Elevated Capital Advisors withdrew a net $62.9M in Q2 2026, closing 21 positions and reducing 292 holdings. Its most notable exit was ExxonMobil, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 64% a quarter earlier, followed by Technology and Financials.

Against the trend, Elevated Capital Advisors opened a new position in AllianzIM U.S. Equity Buffer20 May ETF worth $3.61M.

  • Elevated Capital Advisors's largest Q2 2026 buy was AllianzIM U.S. Equity Buffer20 May ETF: 103,773 shares worth $3.61M.
  • Elevated Capital Advisors added most to AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF in Q2 2026, an estimated $3.09M increase.
  • Elevated Capital Advisors's biggest Q2 2026 reduction was Apple, cutting an estimated $3.77M.
  • Elevated Capital Advisors fully exited ExxonMobil in Q2 2026, selling an estimated $2.76M.
  • Elevated Capital Advisors's ten largest holdings make up 28% of its $364M portfolio in Q2 2026.
  • Elevated Capital Advisors opened 27 new positions and closed 21 in Q2 2026.
  • Elevated Capital Advisors's portfolio value fell 8.5% quarter-over-quarter to $364M.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.